Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples